chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Headache, Musculoskeletal stiffness, Neck pain
Clinical narrative: neck is stiff; neck is sore; chills; feeling hot; really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (really bad headache), CHILLS (chills), FEELING HOT (feeling hot), MUSCULOSKELETAL STIFFNESS (neck is stiff) and NECK PAIN (neck is sore) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced HEADACHE (really bad headache). On 20-Apr-2021, the patient experienced CHILLS (chills) and FEELING HOT (feeling hot). On 23-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (neck is stiff) and NECK PAIN (neck is sore). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown. On 19-Apr-2021, HEADACHE (really bad headache) had resolved. On 22-Apr-2021, CHILLS (chills) and FEELING HOT (feeling hot) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (neck is stiff) and NECK PAIN (neck is sore) outcome was unknown. Not Provided          Treatment Tylenol   This case was linked to MOD-2021-089706 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination adverse reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided.    This case was linked to MOD21-081072.; Sender's Comments:  MOD21-081072:
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Pyrexia
Clinical narrative: cramping on the stomach; a fever over 101; wiped out; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (cramping on the stomach), PYREXIA (a fever over 101) and FATIGUE (wiped out) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (cramping on the stomach), PYREXIA (a fever over 101) and FATIGUE (wiped out). At the time of the report, ABDOMINAL PAIN UPPER (cramping on the stomach), PYREXIA (a fever over 101) and FATIGUE (wiped out) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-089723 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089723:
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itches all over; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itches all over) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itches all over). At the time of the report, PRURITUS (Itches all over) outcome was unknown.             No concomitant medications were reported.No treatment information was provided.   This case was linked to MOD-2021-089718, MOD-2021-089718 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: pain and a swelling under the arm; pain and a swelling under the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain and a swelling under the arm) and PERIPHERAL SWELLING (pain and a swelling under the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain and a swelling under the arm) and PERIPHERAL SWELLING (pain and a swelling under the arm). At the time of the report, PAIN IN EXTREMITY (pain and a swelling under the arm) and PERIPHERAL SWELLING (pain and a swelling under the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Ear pain, Fatigue, Headache
Clinical narrative: Dizziness; Ears fullness and achy; Rash extended towards elbow; Swollen lymph node under right arm; Soreness at injection site; Developed a big rash in the injection arm; Nausea; Headache; Fatigue; Fevers up to 103; Body chills; Achy body; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm) and VACCINATION SITE PAIN (Soreness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Percocet) and IBD (Microscopic Colitis) since 01-Jan-2020. Concomitant products included BIFIDOBACTERIUM INFANTIS (ALIGN) for Colitis, ATORVASTATIN for Hypercholesterolaemia, VITAMIN D3 for Supplementation therapy, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for Vertigo.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE RASH (Developed a big rash in the injection arm), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Fevers up to 103) and MYALGIA (Achy body). 16-Apr-2021, the patient experienced CHILLS (Body chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) (oral) from 16-Apr-2021 to 19-Apr-2021 for Fever, at a dose of 500 mg and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. On 19-Apr-2021, DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE RASH (Developed a big rash in the injection arm), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Fevers up to 103), CHILLS (Body chills) and MYALGIA (Achy body) had resolved.      This case was linked to MOD-2021-089677 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Added - patient demographics, medical history, 1st and 2nd dose vaccine information, concomitant medications, treatment medication, new events (rash starting at injection site, rash extended towards elbow, dizziness, nausea, fatigue, fevers, swollen lymph node under right arm, ears fullness and achy, body chills, achy body). The outcome of the events changed (from unknown to resolved). On 30-Jul-2021: Follow up received on 30-Jul-2021 and contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Nausea, Pyrexia, Rash
Clinical narrative: Dizziness; Ears fullness and achy; Rash extended towards elbow; Swollen lymph node under right arm; Soreness at injection site; Developed a big rash in the injection arm; Nausea; Headache; Fatigue; Fevers up to 103; Body chills; Achy body; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm) and VACCINATION SITE PAIN (Soreness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Percocet) and IBD (Microscopic Colitis) since 01-Jan-2020. Concomitant products included BIFIDOBACTERIUM INFANTIS (ALIGN) for Colitis, ATORVASTATIN for Hypercholesterolaemia, VITAMIN D3 for Supplementation therapy, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for Vertigo.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE RASH (Developed a big rash in the injection arm), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Fevers up to 103) and MYALGIA (Achy body). 16-Apr-2021, the patient experienced CHILLS (Body chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) (oral) from 16-Apr-2021 to 19-Apr-2021 for Fever, at a dose of 500 mg and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. On 19-Apr-2021, DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE RASH (Developed a big rash in the injection arm), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Fevers up to 103), CHILLS (Body chills) and MYALGIA (Achy body) had resolved.      This case was linked to MOD-2021-089677 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Added - patient demographics, medical history, 1st and 2nd dose vaccine information, concomitant medications, treatment medication, new events (rash starting at injection site, rash extended towards elbow, dizziness, nausea, fatigue, fevers, swollen lymph node under right arm, ears fullness and achy, body chills, achy body). The outcome of the events changed (from unknown to resolved). On 30-Jul-2021: Follow up received on 30-Jul-2021 and contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Dizziness; Ears fullness and achy; Rash extended towards elbow; Swollen lymph node under right arm; Soreness at injection site; Developed a big rash in the injection arm; Nausea; Headache; Fatigue; Fevers up to 103; Body chills; Achy body; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm) and VACCINATION SITE PAIN (Soreness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Percocet) and IBD (Microscopic Colitis) since 01-Jan-2020. Concomitant products included BIFIDOBACTERIUM INFANTIS (ALIGN) for Colitis, ATORVASTATIN for Hypercholesterolaemia, VITAMIN D3 for Supplementation therapy, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for Vertigo.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE RASH (Developed a big rash in the injection arm), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Fevers up to 103) and MYALGIA (Achy body). 16-Apr-2021, the patient experienced CHILLS (Body chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) (oral) from 16-Apr-2021 to 19-Apr-2021 for Fever, at a dose of 500 mg and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. On 19-Apr-2021, DIZZINESS (Dizziness), EAR PAIN (Ears fullness and achy), RASH (Rash extended towards elbow), LYMPHADENOPATHY (Swollen lymph node under right arm), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE RASH (Developed a big rash in the injection arm), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Fevers up to 103), CHILLS (Body chills) and MYALGIA (Achy body) had resolved.      This case was linked to MOD-2021-089677 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Added - patient demographics, medical history, 1st and 2nd dose vaccine information, concomitant medications, treatment medication, new events (rash starting at injection site, rash extended towards elbow, dizziness, nausea, fatigue, fevers, swollen lymph node under right arm, ears fullness and achy, body chills, achy body). The outcome of the events changed (from unknown to resolved). On 30-Jul-2021: Follow up received on 30-Jul-2021 and contains no new information.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching all over; This spontaneous case was reported by an other and describes the occurrence of PRURITUS (itching all over) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching all over). At the time of the report, PRURITUS (itching all over) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event were not provided.  No laboratory investigations were provided. The Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-089713 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Pyrexia
Clinical narrative: Cramping of the stomach; fever over 101; This spontaneous case was reported by a non-health professional and describes the occurrence of ABDOMINAL PAIN UPPER (Cramping of the stomach) and PYREXIA (fever over 101) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (For crushed both heels.) from 15-Apr-2021 to 16-Apr-2021. Concurrent medical conditions included Diabetic (Type 1).    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Cramping of the stomach) and PYREXIA (fever over 101). At the time of the report, ABDOMINAL PAIN UPPER (Cramping of the stomach) and PYREXIA (fever over 101) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment medication was not provided.     This case was linked to US-MODERNATX, INC.-MOD-2021-089712 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089712:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Tinnitus
Clinical narrative: Tinnitus; hard to fall asleep and even woke him up at times; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) and INSOMNIA (hard to fall asleep and even woke him up at times) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced TINNITUS (Tinnitus) and INSOMNIA (hard to fall asleep and even woke him up at times). At the time of the report, TINNITUS (Tinnitus) and INSOMNIA (hard to fall asleep and even woke him up at times) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medications was not  provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Feeling abnormal
Clinical narrative: "felt bad"; "eyes swole up"; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL ("felt bad") and EYE SWELLING ("eyes swole up") in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anaphylactic reaction (anaphylactic response to carrots).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced FEELING ABNORMAL ("felt bad") and EYE SWELLING ("eyes swole up"). On 27-Mar-2021, FEELING ABNORMAL ("felt bad") had resolved. On 29-Mar-2021, EYE SWELLING ("eyes swole up") had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Pharmacist states patient is presenting for her second dose but he is unsure to give it because of her reactions she is reporting to him now. No Concomitant medications were reported   Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness, Vision blurred
Clinical narrative: numbness on my left cheek; left hand was week; vision in my left eye was blurry; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness on my left cheek), MUSCULAR WEAKNESS (left hand was week) and VISION BLURRED (vision in my left eye was blurry) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness on my left cheek), MUSCULAR WEAKNESS (left hand was week) and VISION BLURRED (vision in my left eye was blurry). At the time of the report, HYPOAESTHESIA (numbness on my left cheek), MUSCULAR WEAKNESS (left hand was week) and VISION BLURRED (vision in my left eye was blurry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced FATIGUE (Tired). At the time of the report, FATIGUE (Tired) outcome was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Limb discomfort, Muscular weakness, Pyrexia
Clinical narrative: Rubbery legs; Unable to move legs; Weakness; Fever; Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of LIMB DISCOMFORT (Rubbery legs), MUSCULAR WEAKNESS (Unable to move legs), ASTHENIA (Weakness), PYREXIA (Fever) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Rubbery legs), MUSCULAR WEAKNESS (Unable to move legs), ASTHENIA (Weakness), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, LIMB DISCOMFORT (Rubbery legs), MUSCULAR WEAKNESS (Unable to move legs), ASTHENIA (Weakness), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products and treatment medication were reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Off label use
Clinical narrative: Covid infection after first dose of Moderna vaccine; HCP who told her to wait for 90 days before second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid infection after first dose of Moderna vaccine) and OFF LABEL USE (HCP who told her to wait for 90 days before second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid infection after first dose of Moderna vaccine) and OFF LABEL USE (HCP who told her to wait for 90 days before second dose). At the time of the report, COVID-19 (Covid infection after first dose of Moderna vaccine) and OFF LABEL USE (HCP who told her to wait for 90 days before second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by the reporter. No treatment medications were provided by the reporter.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Eye swelling, Fatigue, Headache, Pain in extremity
Clinical narrative: Eyes swollen shut; Tingling/prickling/burning in the legs; Intermittent ringing in the ears; Sore arm; Hives; Fever of 102.2; Fatigue; Frequent headaches; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Eyes swollen shut), PARAESTHESIA (Tingling/prickling/burning in the legs), TINNITUS (Intermittent ringing in the ears), PAIN IN EXTREMITY (Sore arm) and URTICARIA (Hives) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Hypercholesterolaemia. Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA) for Diabetes, ATORVASTATIN for Hypercholesterolaemia.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced EYE SWELLING (Eyes swollen shut), PARAESTHESIA (Tingling/prickling/burning in the legs), TINNITUS (Intermittent ringing in the ears), PAIN IN EXTREMITY (Sore arm), URTICARIA (Hives), PYREXIA (Fever of 102.2), FATIGUE (Fatigue) and HEADACHE (Frequent headaches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, EYE SWELLING (Eyes swollen shut), PARAESTHESIA (Tingling/prickling/burning in the legs), TINNITUS (Intermittent ringing in the ears), PAIN IN EXTREMITY (Sore arm), URTICARIA (Hives), PYREXIA (Fever of 102.2), FATIGUE (Fatigue) and HEADACHE (Frequent headaches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Body temperature: 102.2 (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up received included no newsignificant information. On 05-Aug-2021: Follow-up information received on 05-AUG-2021 include no new information.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pyrexia, Tinnitus, Urticaria
Clinical narrative: Eyes swollen shut; Tingling/prickling/burning in the legs; Intermittent ringing in the ears; Sore arm; Hives; Fever of 102.2; Fatigue; Frequent headaches; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Eyes swollen shut), PARAESTHESIA (Tingling/prickling/burning in the legs), TINNITUS (Intermittent ringing in the ears), PAIN IN EXTREMITY (Sore arm) and URTICARIA (Hives) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Hypercholesterolaemia. Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA) for Diabetes, ATORVASTATIN for Hypercholesterolaemia.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced EYE SWELLING (Eyes swollen shut), PARAESTHESIA (Tingling/prickling/burning in the legs), TINNITUS (Intermittent ringing in the ears), PAIN IN EXTREMITY (Sore arm), URTICARIA (Hives), PYREXIA (Fever of 102.2), FATIGUE (Fatigue) and HEADACHE (Frequent headaches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, EYE SWELLING (Eyes swollen shut), PARAESTHESIA (Tingling/prickling/burning in the legs), TINNITUS (Intermittent ringing in the ears), PAIN IN EXTREMITY (Sore arm), URTICARIA (Hives), PYREXIA (Fever of 102.2), FATIGUE (Fatigue) and HEADACHE (Frequent headaches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Body temperature: 102.2 (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up received included no newsignificant information. On 05-Aug-2021: Follow-up information received on 05-AUG-2021 include no new information.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lacrimation increased, Tongue discomfort
Clinical narrative: her tongue kind of burnt; right side of the face being "nummy; eye was watering; This spontaneous case was reported by a nurse and describes the occurrence of TONGUE DISCOMFORT (her tongue kind of burnt), HYPOAESTHESIA (right side of the face being "nummy) and LACRIMATION INCREASED (eye was watering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TONGUE DISCOMFORT (her tongue kind of burnt), HYPOAESTHESIA (right side of the face being "nummy) and LACRIMATION INCREASED (eye was watering). At the time of the report, TONGUE DISCOMFORT (her tongue kind of burnt), HYPOAESTHESIA (right side of the face being "nummy) and LACRIMATION INCREASED (eye was watering) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided.    This case was linked to MOD-2021-033980 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Product dose omission issue
Clinical narrative: Allergic reaction on arm; Missed scheduled 2nd dose, interval between doses more than 42 days; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction on arm) and PRODUCT DOSE OMISSION ISSUE (Missed scheduled 2nd dose, interval between doses more than 42 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction on arm) and PRODUCT DOSE OMISSION ISSUE (Missed scheduled 2nd dose, interval between doses more than 42 days). At the time of the report, HYPERSENSITIVITY (Allergic reaction on arm) outcome was unknown. Not Provided   No concomitant and treatment details were provided.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was 17 years had the first dose of vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 17 years had the first dose of vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 17 years had the first dose of vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 17 years had the first dose of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment provided.  No concomitant medications were provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Pain in extremity, Vaccination site irritation, Vaccination site rash
Clinical narrative: Blotchy Area (2" wide) Injection Site; Rash (2" wide) on the Injection Site; Itchy Injection Site; Sore Left Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm), VACCINATION SITE IRRITATION (Blotchy Area (2" wide) Injection Site), VACCINATION SITE RASH (Rash (2" wide) on the Injection Site) and INJECTION SITE PRURITUS (Itchy Injection Site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm). On 22-Apr-2021, the patient experienced VACCINATION SITE IRRITATION (Blotchy Area (2" wide) Injection Site), VACCINATION SITE RASH (Rash (2" wide) on the Injection Site) and INJECTION SITE PRURITUS (Itchy Injection Site). On 16-Apr-2021, PAIN IN EXTREMITY (Sore Left Arm) had resolved. At the time of the report, VACCINATION SITE IRRITATION (Blotchy Area (2" wide) Injection Site), VACCINATION SITE RASH (Rash (2" wide) on the Injection Site) and INJECTION SITE PRURITUS (Itchy Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Patient used for treatment Benadryl and ice Pak on the rash area.
Sex: F
Vaccine: COVID19
Symptoms: Breast feeding, Myalgia, Pyrexia
Clinical narrative: minor fever; aches; breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (minor fever), MYALGIA (aches) and BREAST FEEDING (breastfeeding) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (minor fever), MYALGIA (aches) and BREAST FEEDING (breastfeeding). At the time of the report, PYREXIA (minor fever), MYALGIA (aches) and BREAST FEEDING (breastfeeding) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided  Treatment medication was not provided by the reporter    This case was linked to US-MODERNATX, INC.-MOD-2021-089594 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089594:case for daughter
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: Arm was sore; Rash on the injection Site onset about 1 week after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore) and VACCINATION SITE RASH (Rash on the injection Site onset about 1 week after vaccination) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was sore) and VACCINATION SITE RASH (Rash on the injection Site onset about 1 week after vaccination). At the time of the report, PAIN IN EXTREMITY (Arm was sore) and VACCINATION SITE RASH (Rash on the injection Site onset about 1 week after vaccination) had resolved.            No concomitant medications were provided Treatment for the events were not provided   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Patient demographics updated. Additional event was added
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Tinnitus
Clinical narrative: ringing of the ear; Rashes; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing of the ear) and RASH (Rashes) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0210A21A and 013L201A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included PANTOPRAZOLE and PSYLLIUM HYDROPHILIC MUCILLOID (METAMUCIL [PSYLLIUM HYDROPHILIC MUCILLOID]) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced TINNITUS (ringing of the ear) and RASH (Rashes). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, TINNITUS (ringing of the ear) and RASH (Rashes) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Pyrexia, Vaccination site reaction
Clinical narrative: 104 fever; verysick; Pretty severe reactions; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (104 fever), ILLNESS (verysick) and VACCINATION SITE REACTION (Pretty severe reactions) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (104 fever), ILLNESS (verysick) and VACCINATION SITE REACTION (Pretty severe reactions). At the time of the report, PYREXIA (104 fever), ILLNESS (verysick) and VACCINATION SITE REACTION (Pretty severe reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant product use was not provided.    This case was linked to MOD-2021-034634 (Linked Report).; Sender's Comments:  MOD-2021-034634:Crosslinked, case of his child
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS], VITAMIN D3, PSYLLIUM HYDROPHILIC MUCILLOID (METAMUCIL [PSYLLIUM HYDROPHILIC MUCILLOID]) from 01-Jan-2000 to an unknown date, MAGNESIUM, ATHLETIC GREENS from 01-Jan-2000 to an unknown date and VITAMIN D [VITAMIN D NOS] from 01-Jan-2000 to an unknown date for an unknown indication.    On 09-Mar-2021 at 8:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       for mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment.   This case was linked to MOD-2021-089766 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Added patient's demographics and concomitant medications.
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ZOLMITRIPTAN for Migraine.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 24-Feb-2021, the patient experienced MIGRAINE (migraine). On 28-Feb-2021, MIGRAINE (migraine) had resolved.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac
Clinical narrative: Had a stress test after the first shot which made them do cardiac catheterization; This spontaneous case was reported by a consumer and describes the occurrence of CATHETERISATION CARDIAC (Had a stress test after the first shot which made them do cardiac catheterization) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CATHETERISATION CARDIAC (Had a stress test after the first shot which made them do cardiac catheterization). At the time of the report, CATHETERISATION CARDIAC (Had a stress test after the first shot which made them do cardiac catheterization) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Lab data include stress test.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Myalgia, Pyrexia, Tinnitus
Clinical narrative: general fever; body aches; Both ears started ringing really loud; Head felt really full; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Both ears started ringing really loud), HEAD DISCOMFORT (Head felt really full), PYREXIA (general fever) and MYALGIA (body aches) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Moderna 038B21A and Mod-001B21A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3 for Vitamin deficiency, MULTIVITAMIN & MINERAL, PLANTAGO OVATA (METAMUCIL REGULAR) and MAGNESIUM for an unknown indication.   On 09-Mar-2021 at 7:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021 at 7:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021 at 7:45 PM, the patient experienced TINNITUS (Both ears started ringing really loud). 06-Apr-2021 at 7:45 PM, the patient experienced HEAD DISCOMFORT (Head felt really full). On 07-Apr-2021, the patient experienced PYREXIA (general fever) and MYALGIA (body aches). The patient was treated with MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) at an unspecified dose and frequency and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency. On 07-Apr-2021, PYREXIA (general fever) and MYALGIA (body aches) had resolved. At the time of the report, TINNITUS (Both ears started ringing really loud) and HEAD DISCOMFORT (Head felt really full) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA 1273 ( Moderna) vaccine was not applicable   This case was linked to MOD-2021-089754 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: email updated, patient demographics were updated, concomitants were updated ,dosage regimen updated
Sex: U
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: Eye floaters; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (Eye floaters) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Eye floaters.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VITREOUS FLOATERS (Eye floaters). At the time of the report, VITREOUS FLOATERS (Eye floaters) was resolving.            No treatment medications were reported. No concomitant medications were reported. Patient may be looked after with eye drop or something better.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Additional document attched On 23-Jun-2021: Received additional information